Dana B. Hancock is a genetic epidemiologist and senior director of the GenOmics, Bioinformatics, and Translational Research Center in the Biostatistics and Epidemiology Division. Her research focuses on identifying and characterizing genetic, epigenetic, and environmental risk factors and their interactions for complex human diseases and traits.
With more than 15 years of experience, she has worked in highly collaborative settings with investigators across the United States and worldwide to conduct targeted gene and genome-wide association studies for neurologic, respiratory, immunologic, and addiction (including, nicotine and opioids) outcomes. Dr. Hancock is also experienced in leveraging epigenetics and other layers of biological information to better understand genetic risk factors and their interactions.
Dr. Hancock is currently principal investigator or co-investigator of several National Institutes of Health (NIH)–funded studies. She has authored more than 70 peer-reviewed journal articles, book chapters, and other correspondences, and her professional service has included standing study section memberships in the North Carolina Translational and Clinical Sciences Institute and the Center for Scientific Review (Behavioral Genetics and Epidemiology) at the NIH
